Compound Evidence File
#EC-2026-0458
Cartalax
Filed under Peptides. The bureau holds 177 laboratory returns for this compound from 72 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
72 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 7 Jan 2026 | 22 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 15 Apr 2026 | 4 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 10.0 | 10.0 | 1 Apr 2026 | 9 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 10.0 | 10.0 | 14 Jan 2026 | 16 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 9.9 | 10.0 | 17 Jul 2026 | 19 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Jan 2026 | 20 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 10 Feb 2026 | 26 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 10.0 | 10.0 | 10.0 | 24 Mar 2026 | 4 Apr 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 19 Jun 2026 | 9 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 21 Mar 2026 | 12 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 17 Dec 2025 | 9 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 19 Dec 2025 | 23 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 22 Nov 2025 | 17 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 6 Mar 2026 | 27 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Feb 2026 | 15 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 10 Apr 2026 | 19 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 9.9 | 9.9 | 10.0 | 22 Mar 2026 | 21 Apr 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Jun 2026 | 8 Aug 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 9.9 | 19 Dec 2025 | 20 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 9.9 | 3 Jun 2026 | 4 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 9.9 | 8 Jul 2026 | 26 Jul 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 2 | 9.6 | 9.2 | 10.0 | 28 Mar 2025 | 21 May 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 9.4 | 9.4 | 9.4 | 7 May 2025 | 7 May 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 3 | 9.2 | 8.3 | 9.9 | 21 May 2026 | 21 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | X | 3 | 8.9 | 8.1 | 10.0 | 28 Mar 2025 | 25 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | X | 3 | 8.7 | 8.0 | 9.8 | 20 Jun 2025 | 21 May 2026 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 8.6 | 8.6 | 8.6 | 21 May 2025 | 21 May 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 8.6 | 8.6 | 8.6 | 27 Feb 2025 | 27 Feb 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.5 | 6.0 | 9.3 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.4 | 7.6 | 9.7 | 21 May 2026 | 21 May 2026 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 8.3 | 8.3 | 8.3 | 2 Jul 2025 | 2 Jul 2025 |
| ZhuoYan labCASE #VI-2026-0902 | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 | 21 May 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.0 | 6.0 | 10.0 | 23 May 2026 | 23 May 2026 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 8.0 | 8.0 | 8.0 | 13 Feb 2025 | 13 Feb 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 2 | 7.9 | 6.4 | 9.4 | 24 Apr 2025 | 17 May 2026 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 7.8 | 7.8 | 7.8 | 7 May 2025 | 7 May 2025 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 7.7 | 7.7 | 7.7 | 9 Jun 2025 | 9 Jun 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 7.6 | 6.3 | 8.6 | 24 May 2026 | 24 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.6 | 7.6 | 7.6 | 9 Jun 2025 | 9 Jun 2025 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 2 | 7.5 | 6.6 | 8.5 | 2 Apr 2025 | 25 May 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 1 | 7.4 | 7.4 | 7.4 | 3 Jun 2025 | 3 Jun 2025 |
| OupeptideCASE #VI-2026-0435 | X | 9 | 7.1 | 5.0 | 8.8 | 3 Jun 2025 | 26 Jan 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 | 16 Mar 2025 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 | 16 Mar 2025 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 7.0 | 7.0 | 7.0 | 7 May 2025 | 7 May 2025 |
| HealthTide BiotechCASE #VI-2026-0955 | X | 1 | 6.9 | 6.9 | 6.9 | 3 Jun 2025 | 3 Jun 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 4 | 6.8 | 5.4 | 9.5 | 6 May 2025 | 20 May 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 6.5 | 6.5 | 6.5 | 14 Jan 2025 | 14 Jan 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 6.4 | 6.4 | 6.4 | 20 Jun 2025 | 20 Jun 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 2 | 6.3 | 6.1 | 6.6 | 13 Jun 2025 | 24 May 2026 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 6.3 | 6.3 | 6.3 | 11 Jun 2025 | 11 Jun 2025 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 1 | 6.3 | 6.3 | 6.3 | 27 Feb 2025 | 27 Feb 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 6.1 | 6.1 | 6.1 | 3 Jun 2025 | 3 Jun 2025 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 3 | 5.3 | 4.5 | 6.5 | 9 Jun 2025 | 19 Jan 2026 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 2 | 5.1 | 4.6 | 5.6 | 13 Jun 2025 | 24 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 5.1 | 5.1 | 5.1 | 11 Jun 2025 | 11 Jun 2025 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 2 | 4.8 | 4.6 | 5.1 | 21 May 2025 | 24 May 2026 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 4.7 | 4.7 | 4.7 | 17 Dec 2024 | 17 Dec 2024 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 4.6 | 4.6 | 4.6 | 14 Jan 2025 | 14 Jan 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 2 | 4.5 | 4.3 | 4.7 | 2 Apr 2025 | 21 May 2026 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 4.4 | 4.4 | 4.4 | 13 Jun 2025 | 13 Jun 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 3.8 | 3.8 | 3.8 | 20 Jun 2025 | 20 Jun 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 3.8 | 3.8 | 3.8 | 16 Mar 2025 | 16 Mar 2025 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 3.2 | 3.2 | 3.2 | 25 Apr 2025 | 25 Apr 2025 |
| Zztai PeptideCASE #VI-2026-0192 | X | 1 | 3.0 | 3.0 | 3.0 | 11 Jun 2025 | 11 Jun 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 2.7 | 2.7 | 2.7 | 13 Jun 2025 | 13 Jun 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 1.6 | 1.6 | 1.6 | 28 Mar 2025 | 28 Mar 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 1 | 1.5 | 1.5 | 1.5 | 13 Feb 2025 | 13 Feb 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 1.0 | 1.0 | 1.0 | 11 Jun 2025 | 11 Jun 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 20 Jun 2025 | 20 Jun 2025 |
Open any subject to view the batch-level evidence for Cartalax alone.